In ovarian cancer, IDO plays a role in inhibiting the proliferation and killing of NK cells as well as effector T cells, and high expression of IDO in tumor cells is associated with a decrease in the number of lymphocytes, tumor infiltration and peritoneal spread but has no effect on the growth of cancer cells (Wang et al., 2012). This evidence concerns the gene IDO1 and neoplasm.